KLK3 and prostate carcinoma: Several studies have investigated SCNA in prostate cancer [10–12], and critically, it has been established that the burden of SCNA is associated with subsequent biochemical recurrence (rising Prostate Specific Antigen, PSA, levels after radical prostatectomy) and metastasis independent of initial PSA levels and Gleason scores.